Literature DB >> 9186844

Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats.

S S Wang1, F Y Lee, S L Wu, C M Hwu, C H Chien, S D Lee, Y T Tsai, Y Chao, C C Chen, P S Wang.   

Abstract

BACKGROUND/AIMS: To realize the roles of peripheral vasodilatation and atrial natriuretic peptide in the formation of cirrhotic ascites, the effects of long-term administration of octreotide on carbon tetrachloride-induced cirrhotic rats were evaluated.
METHODS: Urine sodium excretion, hemodynamics, plasma atrial natriuretic peptide levels, renin activities and aldosterone concentrations were compared between cirrhotic and control rats (protocol 1); and between octreotide- (65 micrograms/kg, twice daily for 10 days, subcutaneously) and placebo-treated (5% dextrose) cirrhotic rats (protocol 2). In an in vitro experiment, right atrial tissue of cirrhotic rats was incubated with different concentrations of octreotide to evaluate the release of atrial natriuretic peptide (protocol 3).
RESULTS: Cirrhotic rats had significantly lower urine sodium excretion and systemic vascular resistance, and significantly higher plasma atrial natriuretic peptide levels, renin activities and aldosterone concentrations than control rats. Compared with placebo-treated cirrhotic rats, octreotide caused increased urine sodium excretion (-10 +/- 4% vs. 13 +/- 8% from baseline values, p < 0.05) and systemic vascular resistance (2.6 +/- 0.1 vs. 3.3 +/- 0.3 mmHg.min.100 g.ml-1, p < 0.05); and decreased plasma atrial natriuretic peptide levels (166.7 +/- 24.8 vs. 234.0 +/- 19.2 pg/ ml, p < 0.05), renin activities (2.45 +/- 0.49 vs. 4.36 +/- 0.53 ng.ml-1.h-1, p < 0.01) and aldosterone concentrations (290.2 +/- 40.0 vs. 483.3 +/- 82.6 pg/ml, p < 0.05). In the in vitro experiment, right atrial release of atrial natriuretic peptide of cirrhotic rats was not significantly changed when incubated with different concentrations of octreotide.
CONCLUSIONS: Octreotide ameliorates renal sodium retention and suppresses plasma levels of atrial natriuretic peptide of ascitic cirrhotic rats with a novel mechanism via, at least partly, the modification of peripheral vascular resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186844     DOI: 10.1016/s0168-8278(97)80122-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

1.  The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.

Authors:  Pierluigi Toniutto; Mario Pirisi; Carlo Fabris; Luca Apollonio; Kalliopi Sereti; Ettore G Bartoli
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

2.  Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis.

Authors:  Nary Veal; Frédéric Moal; Frédéric Oberti; Eric Vuillemin; Paul Calés
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.

Authors:  M Sàbat; C Guarner; G Soriano; O Bulbena; M T Novella; J Ortiz; E Ricart; C Villanueva; J Rosello; J Rodríguez; J Balanzó
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.